日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study

奥法妥木单抗维持治疗可延长复发性慢性淋巴细胞白血病患者的无进展生存期:PROLONG 研究的最终分析

van Oers, Marinus; Smolej, Lukas; Petrini, Mario; Offner, Fritz; Grosicki, Sebastian; Levin, Mark-David; Davis, Jaclyn; Banerjee, Hiya; Stefanelli, Tommaso; Hoever, Petra; Geisler, Christian

Formulation development for the orexin receptor antagonist almorexant: assessment in two clinical studies

食欲素受体拮抗剂阿莫雷沙特的制剂开发:两项临床研究的评估

Dingemanse, Jasper; Gehin, Martine; Cruz, Hans Gabriel; Hoever, Petra

Absence of pharmacokinetic and pharmacodynamic interactions between almorexant and warfarin in healthy subjects

在健康受试者中,阿莫雷沙特与华法林之间不存在药代动力学和药效学相互作用

Dingemanse, Jasper; Hoever, Petra

Development of antiviral therapy for severe acute respiratory syndrome

严重急性呼吸综合征抗病毒疗法的研发

Cinatl, Jindrich Jr; Michaelis, Martin; Hoever, Gerold; Preiser, Wolfgang; Doerr, Hans Wilhelm

Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus

严重急性呼吸综合征冠状病毒感染培养的肠上皮细胞

Cinatl, J Jr; Hoever, G; Morgenstern, B; Preiser, W; Vogel, J-U; Hofmann, W-K; Bauer, G; Michaelis, M; Rabenau, H F; Doerr, H W